Other Clinical Trials
- This is a Phase 2 study to evaluate the ophthalmic drop CA201A for the prevention of corneal endothelial cell loss in subjects undergoing cataract surgery. The study aims to improve corneal clarity and visual recovery after surgery.
- Study Duration: 12 Weeks